...
首页> 外文期刊>Infection and immunity >Regulated Delayed Expression of rfaH in an Attenuated Salmonella enterica Serovar Typhimurium Vaccine Enhances Immunogenicity of Outer Membrane Proteins and a Heterologous Antigen
【24h】

Regulated Delayed Expression of rfaH in an Attenuated Salmonella enterica Serovar Typhimurium Vaccine Enhances Immunogenicity of Outer Membrane Proteins and a Heterologous Antigen

机译:减毒肠炎沙门氏菌鼠伤寒沙门氏菌疫苗中rfaH的调控的延迟表达增强了外膜蛋白和异源抗原的免疫原性。

获取原文
           

摘要

RfaH is a transcriptional antiterminator that reduces the polarity of long operons encoding secreted and surface-associated cell components of Salmonella enterica serovar Typhimurium, including O antigen and lipopolysaccharide core sugars. A ΔrfaH mutant strain is attenuated in mice (50% lethal dose [LD50], >108 CFU). To examine the potential for using rfaH in conjunction with other attenuating mutations, we designed a series of strains in which we replaced the native rfaH promoter with the tightly regulated arabinose-dependent araC PBAD promoter so that rfaH expression was dependent on exogenously supplied arabinose provided during in vitro growth. Following colonization of host lymphoid tissues, where arabinose was not available, the PBAD promoter was no longer active and rfaH was not expressed. In the absence of RfaH, O antigen and core sugars were not synthesized. We constructed three mutant strains that expressed different levels of RfaH by altering the ribosome-binding sequence and start codon. One mutation, ΔPrfaH178, was introduced into the attenuated vaccine strain χ9241 (ΔpabA ΔpabB ΔasdA) expressing the pneumococcal surface protein PspA from an Asd+ balanced-lethal plasmid. Mice immunized with this strain and boosted 4 weeks later induced higher levels of serum immunoglobulin G specific for PspA and for outer membrane proteins from other enteric bacteria than either an isogenic ΔrfaH derivative or the isogenic RfaH+ parent. Eight weeks after primary oral immunization, mice were challenged with 200 LD50 of virulent Streptococcus pneumoniae WU2. Immunization with ΔPrfaH178 mutant strains led to increased levels of protection compared to that of the parent χ9241 and of a ΔrfaH derivative of χ9241.
机译:RfaH是一种转录抗终止剂,可减少编码 Salmonella enterica 鼠伤寒沙门氏菌(包括O抗原和脂多糖核心糖)分泌的和表面相关的细胞组分的长操纵子的极性。在小鼠中减毒了Δ rfaH 突变株(50%致死剂量[LD 50 ],> 10 8 CFU)。为了检查将 rfaH 与其他减毒突变结合使用的潜力,我们设计了一系列菌株,其中我们用严格调节的阿拉伯糖依赖性 rfaH 启动子代替了天然的 rfaH 启动子。 em> araC P BAD 启动子,因此 rfaH 表达依赖于体外生长过程中提供的外源性阿拉伯糖。在无法获得阿拉伯糖的宿主淋巴组织定植后,P BAD 启动子不再起作用, rfaH 也未表达。在没有RfaH的情况下,不能合成O抗原和核心糖。我们构建了三个通过改变核糖体结合序列和起始密码子来表达不同水平的RfaH的突变菌株。将一种突变ΔP rfaH178 引入减毒疫苗株χ9241(Δ pabA Δ pabB Δ asdA )从Asd + 平衡致死质粒中表达肺炎球菌表面蛋白PspA。用该菌株免疫并加强免疫后4周的小鼠诱导的PspA和其他肠细菌外膜蛋白特异的血清免疫球蛋白G水平高于同基因Δ rfaH 衍生物或同基因RfaH + 父级。初次口服免疫后八周,小鼠接受200 LD 50 强毒的 S 链球菌 肺炎 WU2攻击。相对于亲本χ9241和χ9241的Δ rfaH 衍生物,ΔP rfaH178 突变株的免疫导致保护水平的提高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号